agilon health, inc.
NYSEAGL is in the middle of one of the most dramatic reratings in health care this year — and the Street is scrambling to keep up. The stock gained 27% this week alone, hitting $88.20 as of Tuesday's close. The one-month move is close to 194%. The catalyst was a Q1 earnings print on May 6 that triggered a 127% single-day surge, followed by a 169% five-day follow-through. That kind of…
AGL cost to borrow surges to 2.86%, up 120% over one week as availability skyrockets to 2,537% of short interest.
AGL is in the middle of one of the most dramatic reratings in health care this year — and the Street is scrambling to keep up. The stock gained 27% this week alone, hitting $88.20 as of Tuesday's close. The one-month…
AGL heads into the post-earnings session having tripled from the canvas — and the Street's response is already turning cooler. The stock closed Tuesday at $26.74, up 149% over the past month. That recovery traces…
Snapshot as of 23 Jun 2026
AGL enters its Q1 2026 earnings release tomorrow with the sharpest analyst signal of the pre-print period arriving just hours ago: JP Morgan's Lisa Gill downgraded the stock to Underweight with a $21 target — a direct…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AGL — free to start on ORTEX.
Sign up for free →Open AGL on ORTEX